| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Urology, Changhai Hospital, Second Military Medical University, Shanghai, China.
| Correspondence to: Dr Ying-hao Sun, Department of Urology, Changhai Hospital, 174 Changhai Road, Shanghai 200433, China. |
-dihydrotestosterone (DHT) produced fast and transient increases in
intracellular Ca2+ in LNCaP cells in a concentration-dependent
manner. These effects were abolished by extracellular Ca2+ removal
or pretreatment with L-type Ca2+ channel inhibitors (nifedipine,
verapamil, and diltiazem). Pretreatment with endoplasmic reticulum ryanodine
receptor blocker (procaine) or phospholipase C inhibitor (neomycin sulfate)
did not alter DHT-induced Ca2+ influx. The concentration of
Ca2+ was also increased by impermeable testosterone conjugated to
bovine serum albumin. Neither an antagonist of intracellular androgen
receptors (cyproterone acetate) nor a protein synthesis inhibitor
(cycloheximide) affected this fast Ca2+ influx. Furthermore, the
effect of DHT was abolished in cells incubated with a G protein inhibitor
(pertussis toxin) and a nonhydrolyzable analog of guanosine triphosphate
(guanosine 5-[b-thio]disphosphate) but not in cells incubated with the
tyrosine kinase inhibitor genistein. These results indicate that androgens
induced an L-type calcium channeldependent intracellular
Ca2+ increase in LNCaP prostate cancer cells. The rapid responses
triggered by DHT did not appear to be mediated through classic intracellular
androgen receptors, c-Src kinase-androgen receptor complex, or sex
hormonebinding globulin but through a G proteincoupled receptor
in LNCaP prostate cancer cells. These results may provide a new explanation
for progression of prostate cancer.
Key words: 5
-Dihydrostestosterone, Ca2+, GPCR
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |